Vivek Ramaswamy 13D and 13G filings for Roivant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 6:53 pm Purchase | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | Vivek Ramaswamy | 82,956,522 11.630% | 1 (+0.00%) | Filing |
| 2025-05-15 5:29 pm Purchase | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | Vivek Ramaswamy | 82,956,521 11.200% | 1,502,000 (+1.84%) | Filing |
| 2024-02-14 4:46 pm Unchanged | 2023-12-31 | 13G | Roivant Sciences Ltd. ROIV | Vivek Ramaswamy | 81,454,521 9.750% | 0 (Unchanged) | Filing |
| 2024-02-13 5:26 pm Sale | 2023-12-31 | 13G | Roivant Sciences Ltd. ROIV | Vivek Ramaswamy | 81,454,521 9.750% | -328,720 (-0.40%) | Filing |
| 2023-02-14 5:20 pm Purchase | 2022-12-31 | 13G | Roivant Sciences Ltd. ROIV | Vivek Ramaswamy | 81,783,241 10.900% | 7,381,272 (+9.92%) | Filing |
| 2022-02-14 4:01 pm Purchase | 2021-12-31 | 13G | Roivant Sciences Ltd. ROIV | Vivek Ramaswamy | 74,401,969 10.500% | 74,401,969 (New Position) | Filing |